Description: Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. Anew Medical, Inc. is based in Omaha, Nebraska.
Home Page: www.anewmeds.com
13576 Walnut Street
Omaha,
NE
68144
United States
Phone:
833 931 6330
Officers
| Name | Title |
|---|---|
| Mr. Peter J. Moriarty | Chief Operating Officer |
| Dr. Shalom Z. Hirschman M.D. | Chief Medical Officer of Emeritus & Independent Director |
| Dr. Joseph Sinkule Pharm.D. | Founder, CEO, Chairman of the Board & Secretary |
| Mr. Jeffrey LeBlanc | Chief Financial Officer |
| Dr. Miguel Chillon Rodriguez | Chief Scientific Officer & Consultant |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Financials |
|---|---|
| GIC Group: | Financial Services |
| GIC Industry: | Financial Services |
| GIC Sub-Industry: | Specialized Finance |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 43.3635 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2022-04-29 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |